Davion Healthcare PLC Agrees $13.5 Million Acquisition of Profitable US Home Healthcare Business
Key Highlights
- ➤$13.5 million acquisition agreed for Healthcare Stat Homecare, including $8 million cash
- ➤HSH reported approximately $11.6 million gross receipts and $1.9 million income in 2025
- ➤Davion will issue $5.5 million in shares valued at $13 per share
- ➤Completion expected by 31 December 2026, subject to acquisition agreement terms
- ➤Davion plans further acquisitions of profitable healthcare businesses over the coming year
Expert Statements
Glenn Williams, Chief Executive Officer of Davion Healthcare Plc
“HSH is an established and profitable business that will bring meaningful revenues and earnings to Davion, while giving us a direct presence in home healthcare and opportunities to introduce our monitoring and diagnostic technologies closer to patients. Importantly, this is the first in a planned programme of acquisitions of revenue-generating, profitable healthcare businesses over the coming year, as we look to build a broader and more diversified Group combining our proprietary technologies with established operating businesses. We look forward to working with HSH’s management to support its existing operations and explore opportunities to integrate our technologies into the delivery of care at home.”
Manilal Mathai, Co-owner and Chief Executive Officer of Healthcare Stat Homecare Inc.
“We share Davion’s commitment to improving care for patients outside hospital settings. Joining forces would give us an opportunity to combine HSH’s home healthcare experience with Davion’s technology-led approach, while continuing to focus on the quality and continuity of care we provide to patients and families.”
DUBLIN, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “Group”), a developer of non-invasive health monitoring technologies, announces that it has entered into an agreement dated 27 October 2026 to acquire Healthcare Stat Homecare Inc. (“HSH”), a Pennsylvania-incorporated provider of home healthcare services based in Philadelphia.
The total consideration is $13.5 million, comprising $8 million in cash and $5.5 million in Davion shares issued at an agreed value of $13 per share. Completion is expected on or before 31 December 2026, subject to the terms of the acquisition agreement.
Get started
Create a free account to read the full story.